SUPERNUS PHARMACEUTICALS, INC. Income Taxes Paid
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Income Taxes Paid of $461.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $873.00K, a 92.97% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-03-31 was -$412.00K, a 250.36% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $271.00K, a 97.90% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $3.08M, a 84.26% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2025 was $16.05M, a 69.86% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2024 was $53.25M, a 45.49% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2023 was $36.60M, a 125.94% increase from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2022 was $16.20M, a 35.69% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $461.00K 10-Q · filed 2026-08-03 | $732.00K derived: sum of 3 quarters · filed 2026-08-03 | $3.81M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$412.00K 10-Q · filed 2026-05-05 | -$141.00K derived: sum of 2 quarters · filed 2026-05-05 | $2.94M derived: sum of 3 quarters · filed 2026-05-05 | $15.37M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.35M derived: sum of 2 quarters · filed 2026-03-02 | $15.78M derived: sum of 3 quarters · filed 2026-08-03 | $16.05M 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.51M derived: sum of 2 quarters · filed 2026-08-03 | $15.78M 10-Q · filed 2025-11-06 | $28.69M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $12.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $12.70M 10-Q · filed 2026-08-03 | $25.61M derived: sum of 3 quarters · filed 2026-08-03 | $45.19M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $274.00K 10-Q · filed 2026-05-05 | $13.19M derived: sum of 2 quarters · filed 2026-05-05 | $32.77M derived: sum of 3 quarters · filed 2026-05-05 | $53.19M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $12.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $32.49M derived: sum of 2 quarters · filed 2026-03-02 | $52.92M derived: sum of 3 quarters · filed 2026-03-02 | $53.25M 10-K · filed 2026-03-02 |
| 2024-09-30 | $19.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $40.01M derived: sum of 2 quarters · filed 2025-11-06 | $40.34M 10-Q · filed 2025-11-06 | $49.89M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $20.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $20.76M 10-Q · filed 2025-08-05 | $30.31M derived: sum of 3 quarters · filed 2026-03-02 | $36.93M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $336.00K 10-Q · filed 2025-05-06 | $9.88M derived: sum of 2 quarters · filed 2026-03-02 | $16.50M derived: sum of 3 quarters · filed 2026-03-02 | $36.73M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $16.17M derived: sum of 2 quarters · filed 2026-03-02 | $36.40M derived: sum of 3 quarters · filed 2026-03-02 | $36.60M 10-K · filed 2026-03-02 |
| 2023-09-30 | $6.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $26.85M derived: sum of 2 quarters · filed 2024-11-04 | $27.05M 10-Q · filed 2024-11-04 | $28.70M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $20.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $20.43M 10-Q · filed 2024-08-06 | $22.08M derived: sum of 3 quarters · filed 2025-02-25 | $28.09M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $203.00K 10-Q · filed 2024-05-08 | $1.84M derived: sum of 2 quarters · filed 2025-02-25 | $7.86M derived: sum of 3 quarters · filed 2025-02-25 | $15.93M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $7.66M derived: sum of 2 quarters · filed 2025-02-25 | $15.72M derived: sum of 3 quarters · filed 2025-02-25 | $16.20M 10-K · filed 2025-02-25 |
| 2022-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $14.08M derived: sum of 2 quarters · filed 2023-11-08 | $14.56M 10-Q · filed 2023-11-08 | $14.64M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $8.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.54M 10-Q · filed 2023-08-08 | $8.62M derived: sum of 3 quarters · filed 2023-08-08 | $13.04M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $478.00K 10-Q · filed 2023-05-09 | $557.00K derived: sum of 2 quarters · filed 2023-05-09 | $4.97M derived: sum of 3 quarters · filed 2023-05-09 | $25.37M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.49M derived: sum of 2 quarters · filed 2023-03-09 | $24.89M derived: sum of 3 quarters · filed 2023-03-09 | $25.19M 10-K · filed 2023-03-09 |
| 2021-09-30 | $4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $24.81M derived: sum of 2 quarters · filed 2022-11-09 | $25.11M 10-Q · filed 2022-11-09 | $28.25M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $20.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $20.70M 10-Q · filed 2022-08-08 | $23.84M derived: sum of 3 quarters · filed 2023-03-09 | $65.52M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $301.00K 10-Q · filed 2022-05-12 | $3.44M derived: sum of 2 quarters · filed 2023-03-09 | $45.12M derived: sum of 3 quarters · filed 2023-03-09 | $45.41M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $44.82M derived: sum of 2 quarters · filed 2023-03-09 | $45.10M derived: sum of 3 quarters · filed 2023-03-09 | $45.43M 10-K · filed 2023-03-09 |
| 2020-09-30 | $41.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $41.96M derived: sum of 2 quarters · filed 2021-11-05 | $42.28M 10-Q · filed 2021-11-05 | $57.89M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-06-30 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $607.00K 10-Q · filed 2021-08-06 | $16.21M derived: sum of 3 quarters · filed 2022-04-13 | $27.35M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-03-31 | $324.00K 10-Q · filed 2021-05-07 | $15.93M derived: sum of 2 quarters · filed 2022-04-13 | $27.07M derived: sum of 3 quarters · filed 2022-04-13 | $51.06M derived: sum of 4 quarters · filed 2022-04-13 |
| 2019-12-31 | $15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $26.75M derived: sum of 2 quarters · filed 2022-04-13 | $50.74M derived: sum of 3 quarters · filed 2022-04-13 | $51.54M 10-K · filed 2022-04-13 |
| 2019-09-30 | $11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $35.13M derived: sum of 2 quarters · filed 2020-11-06 | $35.93M 10-Q · filed 2020-11-06 | $40.77M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | $24.80M 10-Q · filed 2020-08-17 | $29.64M derived: sum of 3 quarters · filed 2021-03-08 | $30.29M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $800.00K 10-Q · filed 2020-05-15 | $5.64M derived: sum of 2 quarters · filed 2021-03-08 | $6.29M derived: sum of 3 quarters · filed 2021-03-08 | $29.95M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $5.49M derived: sum of 2 quarters · filed 2021-03-08 | $29.15M derived: sum of 3 quarters · filed 2021-03-08 | $34.77M 10-K · filed 2021-03-08 |
| 2018-09-30 | $651.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $24.31M derived: sum of 2 quarters · filed 2019-11-08 | $29.93M 10-Q · filed 2019-11-08 | $29.38M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $23.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $29.28M 10-Q · filed 2019-08-09 | $28.73M derived: sum of 3 quarters · filed 2020-02-28 | $29.16M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $5.62M 10-Q · filed 2019-05-10 | $5.08M derived: sum of 2 quarters · filed 2020-02-28 | $5.50M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2017-12-31 | -$548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$122.00K derived: sum of 2 quarters · filed 2020-02-28 | $1.59M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.14M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $1.71M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |